# Advisor Review - Advisor 3/3

**Role:** Academic advisor checking for fatal errors
**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Reasoning effort:** high
**Timestamp:** 2026-01-28T19:16:56.065781
**Response ID:** resp_082c78800890bbc100697a5134a38c819384b4ae91280bb224
**Tokens:** 20637 in / 12193 out
**Response SHA256:** a0857339568827dc

---

## 1) DATA–DESIGN ALIGNMENT (CRITICAL)

### a) Treatment timing vs. data coverage
- Data window is **1999–2017**.
- All “first full treatment years” used in estimation are **≤ 2017**:
  - CT **2000** (but excluded in main spec)
  - IN **2006**
  - CA **2016**
  - WA **2017**
- So **max(treatment year) = 2017 ≤ max(data year) = 2017**. No coverage mismatch.

### b) Post-treatment observations exist for treated cohorts
- In the **main estimation sample** (excluding CT), each treated cohort has post-treatment observations:
  - IN: 2006–2017 (12 post-years)
  - CA: 2016–2017 (2 post-years)
  - WA: 2017 (1 post-year)
- This satisfies the minimum DiD requirement (though WA is obviously thin, it is not a data-design impossibility).

### c) Treatment definition consistency
- The stated treatment rule—**treated = 1 only for full calendar years in effect** and **first_treat = first full year**—is internally consistent with Table 1 and with the cohort years used in Table 3 and Table 4.
- Observation counts implied by the design match what’s reported:
  - 51 jurisdictions × 19 years = **969** (full sample)
  - Excluding CT: 50 × 19 = **950** (main sample)

No fatal data-design misalignment found.

---

## 2) REGRESSION SANITY (CRITICAL)

Checked all reported regression tables:

### Table 3
- Coefficients and SEs are within plausible ranges for an outcome measured in suicides per 100,000:
  - C-S ATT = **0.53 (0.19)**; CI matches coefficient ± 1.96×SE
  - TWFE = **−0.43 (0.65)**; CI matches coefficient ± 1.96×SE
- No impossible values (no NA/NaN/Inf; no negative SE; no absurd magnitudes).

### Table 4
- All coefficients/SEs are plausible (including log-outcome spec **0.05 (0.02)**).
- No explosive SEs or coefficients indicating a broken specification.

No fatal regression-output issues found.

---

## 3) COMPLETENESS (CRITICAL)

- Regression tables report **N/observations** and **standard errors** (and Table 3 reports CIs).
- No placeholders (TBD/TODO/XXX/NA) visible in the provided tables/figures.
- Figures referenced (event study; trends; map; pre-trends test) are present in the draft materials you shared.

No fatal completeness gaps found.

---

## 4) INTERNAL CONSISTENCY (CRITICAL)

- Key numbers stated in the abstract/text match the tables:
  - ATT **0.53 (0.19)** and TWFE **−0.43 (0.65)** match Table 3.
  - Observation counts (969 full; 950 excluding CT) are consistent across text and tables.
- Treatment timing (IN 2006; CA 2016; WA 2017; CT 2000) is consistent across sections/tables.

No fatal internal-consistency contradictions found.

---

ADVISOR VERDICT: PASS